SCHEMBL4264907

SCHEMBL4264907

O=C(O)c1cc(=O)cc(-c2ccccc2)[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.61
NFKB1 P19838 1/20 0.61
BLM P54132 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
KDM4E B2RXH2 6/20 0.47
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
HPGD P15428 5/20 0.46
HSD17B10 Q99714 5/20 0.46
ALDH1A1 P00352 2/20 0.46
ERCC1 P07992 1/20 0.46
FEN1 P39748 1/20 0.46
ERCC4 Q92889 1/20 0.46
MEN1 O00255 1/20 0.46
GRIN2D O15399 1/20 0.46
GRIN3B O60391 1/20 0.46
CYP1A2 P05177 1/20 0.46
GLA P06280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9371336 0.82 TAS2R38 (0.55) SMN1; SMN2KDM4EHPGDHSD17B10ALDH1A1
Chelidamic Acid SCHEMBL742928 0.77 ALOX15 (1.00) ALOX15NFKB1BLMSMN1; SMN2KDM4E
SCHEMBL308253 0.76 KDM4E (0.69) KDM4ECASP3SENP8SENP7SENP6
Chelidamic Acid SCHEMBL1176783 0.75 ALOX15 (0.95) ALOX15NFKB1BLMSMN1; SMN2KDM4E
Chelidamic Acid SCHEMBL9658074 0.75 ALOX15 (0.95) ALOX15NFKB1BLMSMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL6335114 0.75 KDM4E (0.67) SMN1; SMN2KDM4ECASP3SENP8SENP7
SCHEMBL316366 0.73 KDM4E (0.47) SMN1; SMN2KDM4EHPGDHSD17B10ALDH1A1
SCHEMBL8341738 0.71 KDM4E (0.67) SMN1; SMN2KDM4ECASP3SENP8SENP7
SCHEMBL27699479 0.68 KDM4E (0.53) SMN1; SMN2KDM4ECASP3SENP8SENP7
SCHEMBL1259832 0.68 HSD17B10 (0.47) ALOX15NFKB1BLMSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090048258-A1 Amide Compound TAKEDA, PHARMACEUTICAL COMPANY LIMITED (JP) 2009-02-19 US disclosed
EP-1845081-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-10-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048258-A1 Amide Compound DLAT, DGAT1, DGAT2 ALOX15 2631/4885NFKB1 2131/4885BLM 4654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.